Embecta Corp.
EMBC- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001872789
In the last 90 days, Embecta Corp. insiders filed 4 open-market purchases and 1 sale; 322 institutions reported holding it in 13F filings for Q2 2026, worth $164.6M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Embecta Corp. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 461 | 10 | 447 | −4 |
| Shares | 54.6M | 47.0K | 57.9M | +3.31M (+6.1%) |
| Value | $1.57B | $1.35M | $1.46B | −$106.4M (−6.8%) |
10 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (58)
Institutions that held Embecta Corp. at the end of Q4 2022 but not at the end of Q3 2022.
Sold out (62)
Institutions that held Embecta Corp. at the end of Q3 2022 and filed for Q4 2022 without it.
Not filed for Q4 2022 yet (10)
Institutions that held Embecta Corp. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Eaton Vance Management | 45,574 | $1.31M |
| Wipfli Financial Advisors LLC, | 664 | $19.0K |
| FourThought Financial, LLC | 233 | $7.00K |
| American Portfolios Advisors | 176 | $5.07K |
| Covington Capital Management | 172 | $5.00K |
| Newfound Research LLC | 97 | $3.00K |
| Pacific Center for Financial Services | 20 | $1.00K |
| Corsicana & Co. | 25 | $1.00K |
| Surevest, LLC | 3 | $0 |
| Strategic Asset Management, LLC | 9 | $0 |